Tagcloud

ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome

MIMS Ireland: February 2009

Adverse reaction reporting

02 February 2009 | Irish Medicines Board

The Irish Medicines Board monitors the safety of authorised medicinal products for human use available on the Irish market, on an on-going basis. Part of this monitoring is carried out through review and evaluation of suspected adverse reactions and the... Read more

Bicalinn

02 February 2009 | New Products

Company: Helsinn Birex Therapeutics Ltd. Legal category: Prescription. HT. Sport permitted. Active ingredient: Bicalutamide 50mg. Description: White round biconvex film-coated tablet. Presentation: 28, €105.00. Indication: Advanced prostate cancer in combination with LHRH analogue therapy or surgical castration.... Read more

Boostrix

02 February 2009 | New Products

Company: GlaxoSmithKline (Ireland) Ltd. Legal category: Prescription. Sport permitted. Active ingredients: Diphtheria toxoid >2 IU, Tetanus toxoid >20 IU, pertussis toxoid 8 mcg, filamentous haemagglutinin 8 mcg, pertactin2.5mcg, adsorbed on aluminium hydroxide, hydrated (Al(OH)3) and aluminium phosphate (AlPO4). Description: Turbid... Read more

Circadin

02 February 2009 | New Products

Company: Lundbeck (Ireland) Ltd Legal category: Prescription. Sport permitted. Active ingredient: Prolonged-release melatonin 2mg. Description: White to off-white, round, biconvex prolonged-release tablets. Presentation: 21, €12.33 (wholesale price). Indication: Monotherapy for the short-term treatment of primary insomnia characterised by poor quality... Read more

Effentora

02 February 2009 | New Products

Company: Cephalon Pharma (Ireland) Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Fentanyl (as citrate) 100mcg, 200mcg, 400mcg, 600mcg, 800mcg. Description: Flat-faced, white, round bevelled-edge tablet, embossed on one side with a C and respectively with 1, 2, 4,... Read more

Increlex

02 February 2009 | New Products

Prescription. HT. Sport prohibited. Ipsen Pharmaceuticals Ltd has expanded its short-stature treatment portfolio with the launch of Increlex (mecasermin), a recombinant DNA-derived human insulin-like growth factor-1 (IGF-1). Increlex is the first and only product licensed in Europe for the long... Read more

Ireven

02 February 2009 | New Products

Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Venlafaxine (HCl) equivalent to venlafaxine 75mg, 150mg. Description: Opaque hard gelatine prolonged-release capsules containing round, biconvex film-coated tablets, with imprint VEN on cap and strength on body. 75mg:... Read more

Venlafaxine Teva

02 February 2009 |

Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Venlafaxine (HCl) equivalent to venlafaxine 37.5mg, 75mg. Contains lactose. Description: Mottled peach, round, flat bevelled tablets, on one side scored and marked 9 on one side of the... Read more

Vidaza

02 February 2009 | New Products

Company: Celgene UK and Ireland Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Azacitidine 100mg. Description: White lyophilised powder for suspension for injection. Presentation: 100mg vial. €381.00. Indications: Treatment of adult patients who are not eligible for haematopoietic stem cell... Read more

Vimpat

02 February 2009 | New Products

Company: UCB (Pharma) Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Lacosamide 50mg, 100mg, 150mg, 200mg (tablets); 15 mg/ml (syrup); 10mg/ml (solution for infusion). Description: Tablets: Respectively, pinkish, dark yellow, salmon or blue oval film-coated tablet debossed with... Read more

Hospira Oxaliplatin Solution For Injection

02 February 2009 | New Presentations

Hospital. Sport permitted. Hospira Ireland Ltd is pleased to announce the launch of Oxaliplatin Solution. Oxaliplatin is now available in a wide range of presentations: 50mg/ 10ml, 100mg/ 20ml and 200mg/ 40ml, offering choice, flexibility and convenience. Oxaliplatin is an... Read more

Mirap Orodispersible Tablets

02 February 2009 | New Presentations

Company: Rowex. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Mirtazapine 15mg, 30mg, 45mg. Description: White to off-white, round, flat tablets with bevelled edges. Presentation: 15mg-30, €11.59; 30mg-30, €23.15; 45mg-30, €34.73. Indication: Major depressive episodes.... Read more

Trimoptin 100mg

02 February 2009 | New Presentations

Company: Athlone Laboratories Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Trimethoprim 100mg. Description: Flat, white, bevelled-edge tablets embossed TR 100. Presentation: 100, €6.32. Indications: Treatment of infections caused by susceptible organisms including most gram-positive and gram-negative aerobic organisms... Read more

Vectibix 400mg

02 February 2009 | New Presentations

Company: Amgen Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Panitumumab 20mg/ml. Description: Solution in vial. Presentation: 400mg/20ml, €1700. Indications: Monotherapy for the treatment of EGFR expressing metastatic colorectal carcinoma with non-mutated (wild-type) KRAS after failure of fluoropyrimidine-, oxaliplatin-, and... Read more

Valeant range of products acquired by MEDA Ireland

02 February 2009 | New this Month

MEDA Ireland wish to announce that they have acquired the Valeant range of products. The MEDA name will begin to appear on the packaging in a phased manner as existing Valeant stock is depleted from the market.... Read more

Betnovate-N Cream 30g Discontinued

02 February 2009 | Discontinued Products

GlaxoSmithKline wishes to announce that Betnovate-N (betamethasone valerate 0.1% w/w. neomycin sulphate 0.5% w/w, cream 30g) will be discontinued on February 27th 2009. This does not affect other products in the Betnovate range.... Read more

Bondronat 6mg Concentrate for Solution for Infusion discontinued

02 February 2009 | Discontinued Products

Roche Products (Ireland) Limited wish to inform you of the discontinuation of one of its products, Bondronat 6mg concentrate for solution of infusion from January 2009. Marketing of this presentation ceased permanently in January 2009 and stock remaining in circulation... Read more

Estraderm TTS 50mcg discontinued

02 February 2009 | Discontinued Products

Novartis Ireland Ltd wishes to announce the discontinuation of Estraderm TTS 50mcg patches, pack size 8, from March 2009. This will not have any effect on Estraderm TTS 25mcg or 100mcg as they will continue to be produced.... Read more